Endoscopic and Clinicopathological Features of Superficial Non-Ampullary Duodenal Tumor Based on the Mucin Phenotypes.

Magnifying endoscopy with narrow-band imaging Mucin phenotype Non-ampullary duodenal tumor

Journal

Digestion
ISSN: 1421-9867
Titre abrégé: Digestion
Pays: Switzerland
ID NLM: 0150472

Informations de publication

Date de publication:
2021
Historique:
received: 13 11 2019
accepted: 07 04 2020
pubmed: 10 6 2020
medline: 4 9 2021
entrez: 10 6 2020
Statut: ppublish

Résumé

We aimed to clarify the endoscopic/clinicopathological features of superficial non-ampullary duodenal epithelial tumors (SNADETs) based on their mucin phenotypes. We analyzed 62 SNADET lesions and classified them based on mucin phenotypic expression. Endoscopic and clinicopathological findings were compared according to mucin phenotypes. Eleven lesions had the gastric phenotype (GP) and 43 lesions had the intestinal phenotype (IP). All GP lesions were located in the first portion of the duodenum, while most IP lesions (72.1%) were located in the second portion (p < 0.01). Tumor size was significantly larger in the GP than in the IP group (14.4 mm vs. 10.2 mm, p < 0.05). Reddish color (72.7% in GP vs. 37.2% in IP, p < 0.05), type 0-I (72.7% vs. 11.6%, p < 0.01), lobular/granular pattern (81.8% vs. 4.7%, p < 0.01), and category 4/5 in Vienna classification (81.8% vs. 30.2%, p < 0.01) were observed significantly more often in the GP than in the IP group. Regarding findings of magnifying endoscopy with narrow-band imaging (M-NBI), white opaque substance (22.2% in GP vs. 89.7% in IP, p < 0.01) and light blue crest (0% vs. 43.6%, p < 0.05) were significantly less frequently observed in the GP group. Oval-shaped marginal epithelium (66.7% vs. 17.9%, p < 0.01), dense pattern (55.6% vs. 2.6%, p < 0.01), and dilatation of the intervening part (100% vs. 12.8%, p < 0.01) were more frequently observed in the GP group. SNADETs showed distinct endoscopic/clinicopathological features according to the mucin phenotype. Tumor location, coloration, macroscopic type, and endoscopic findings including M-NBI are useful to distinguish the mucin phenotypes of SNADETs.

Identifiants

pubmed: 32516774
pii: 000508040
doi: 10.1159/000508040
pmc: PMC8491506
doi:

Substances chimiques

Mucins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-670

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Author(s). Published by S. Karger AG, Basel.

Références

Endoscopy. 2006 Aug;38(8):819-24
pubmed: 17001572
Hepatogastroenterology. 2010 May-Jun;57(99-100):462-7
pubmed: 20698209
World J Gastroenterol. 2015 Nov 7;21(41):11832-41
pubmed: 26557007
Gastrointest Endosc. 2003 Dec;58(6 Suppl):S3-43
pubmed: 14652541
Endosc Int Open. 2015 Dec;3(6):E597-604
pubmed: 26716119
Dig Endosc. 2013 Mar;25(2):147-55
pubmed: 23368762
Clin Cancer Res. 2007 Jan 1;13(1):152-60
pubmed: 17200350
Pancreatology. 2019 Apr;19(3):443-448
pubmed: 30879968
Gastrointest Endosc. 2017 Aug;86(2):329-332
pubmed: 28003118
J Gastroenterol. 2018 Jan;53(1):64-70
pubmed: 28321513
Endosc Int Open. 2018 Jul;6(7):E830-E837
pubmed: 29978002
Dig Endosc. 2014 Mar;26(2):220-7
pubmed: 23621427
Gastrointest Endosc. 2008 Sep;68(3):574-80
pubmed: 18656862
Dig Endosc. 2012 Nov;24(6):419-25
pubmed: 23078433
Am J Surg Pathol. 2017 Mar;41(3):343-353
pubmed: 27984236
Digestion. 2018;97(3):219-227
pubmed: 29428955
Dig Endosc. 2016 May;28(4):379-393
pubmed: 26896760
Dig Endosc. 2014 Apr;26 Suppl 2:23-9
pubmed: 24750144
Am J Surg Pathol. 2014 Nov;38(11):1484-93
pubmed: 25310836
Virchows Arch. 1999 Oct;435(4):452-7
pubmed: 10526011
Endosc Int Open. 2017 Apr;5(4):E297-E302
pubmed: 28382328
World J Gastroenterol. 2013 Jul 14;19(26):4262-6
pubmed: 23864793
Gut. 2002 Jul;51(1):130-1
pubmed: 12077106
Endoscopy. 2009 May;41(5):462-7
pubmed: 19418401
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2195-203
pubmed: 21828233
Dig Endosc. 2010 Oct;22(4):360-5
pubmed: 21175499
PLoS One. 2017 Apr 4;12(4):e0174985
pubmed: 28376132
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Histopathology. 2017 Aug;71(2):200-207
pubmed: 28211946
Gastrointest Endosc. 2009 Sep;70(3):522-31
pubmed: 19576581
Dig Endosc. 2014 Apr;26 Suppl 2:16-22
pubmed: 24750143
World J Gastroenterol. 2014 Sep 21;20(35):12501-8
pubmed: 25253950

Auteurs

Yoichi Akazawa (Y)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Hiroya Ueyama (H)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan, psyro@juntendo.ac.jp.

Sho Tsuyama (S)

Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.

Atsushi Ikeda (A)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Noboru Yatagai (N)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Hiroyuki Komori (H)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Tsutomu Takeda (T)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Kohei Matsumoto (K)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Kenshi Matsumoto (K)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Takashi Hashimoto (T)

Department of Esophageal and Gastroenterological Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Natsumi Tomita (N)

Department of Esophageal and Gastroenterological Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Yoshiaki Kajiyama (Y)

Department of Esophageal and Gastroenterological Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Motohiko Kato (M)

Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.

Takashi Yao (T)

Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.

Akihito Nagahara (A)

Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH